Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361961142> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W4361961142 abstract "<div>Abstract<p><b>Purpose:</b> Telomerase activity is one of the hallmarks of cancer and is a highly relevant therapeutic target. The effects of a novel human telomerase antagonist, imetelstat, on primary human glioblastoma (GBM) tumor-initiating cells were investigated <i>in vitro</i> and <i>in vivo</i>.</p><p><b>Experimental Design:</b> Tumor-initiating cells were isolated from primary GBM tumors and expanded as neurospheres <i>in vitro</i>. The GBM tumor-initiating cells were treated with imetelstat and examined for the effects on telomerase activity levels, telomere length, proliferation, clonogenicity, and differentiation. Subsequently, mouse orthotopic and subcutaneous xenografts were used to assess the <i>in vivo</i> efficacy of imetelstat.</p><p><b>Results:</b> Imetelstat treatment produced a dose-dependent inhibition of telomerase (IC<sub>50</sub> 0.45 μmol/L). Long-term imetelstat treatment led to progressive telomere shortening, reduced rates of proliferation, and eventually cell death in GBM tumor-initiating cells. Imetelstat in combination with radiation and temozolomide had a dramatic effect on cell survival and activated the DNA damage response pathway. Imetelstat is able to cross the blood-brain barrier in orthotopic GBM xenograft tumors. Fluorescently labeled GBM tumor cells isolated from orthotopic tumors, following systemic administration of imetelstat (30 mg/kg every day for three days), showed ∼70% inhibition of telomerase activity. Chronic systemic treatment produced a marked decrease in the rate of xenograft subcutaneous tumor growth.</p><p><b>Conclusion:</b> This preclinical study supports the feasibility of testing imetelstat in the treatment of GBM patients, alone or in combination with standard therapies. Clin Cancer Res; 16(1); 154–63</p></div>" @default.
- W4361961142 created "2023-04-05" @default.
- W4361961142 creator A5004524722 @default.
- W4361961142 creator A5018167935 @default.
- W4361961142 creator A5044684517 @default.
- W4361961142 creator A5049368934 @default.
- W4361961142 creator A5062798238 @default.
- W4361961142 creator A5068741363 @default.
- W4361961142 creator A5072623548 @default.
- W4361961142 creator A5075061660 @default.
- W4361961142 creator A5081012778 @default.
- W4361961142 creator A5087204229 @default.
- W4361961142 date "2023-03-31" @default.
- W4361961142 modified "2023-10-16" @default.
- W4361961142 title "Data from The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth" @default.
- W4361961142 doi "https://doi.org/10.1158/1078-0432.c.6520634" @default.
- W4361961142 hasPublicationYear "2023" @default.
- W4361961142 type Work @default.
- W4361961142 citedByCount "0" @default.
- W4361961142 crossrefType "posted-content" @default.
- W4361961142 hasAuthorship W4361961142A5004524722 @default.
- W4361961142 hasAuthorship W4361961142A5018167935 @default.
- W4361961142 hasAuthorship W4361961142A5044684517 @default.
- W4361961142 hasAuthorship W4361961142A5049368934 @default.
- W4361961142 hasAuthorship W4361961142A5062798238 @default.
- W4361961142 hasAuthorship W4361961142A5068741363 @default.
- W4361961142 hasAuthorship W4361961142A5072623548 @default.
- W4361961142 hasAuthorship W4361961142A5075061660 @default.
- W4361961142 hasAuthorship W4361961142A5081012778 @default.
- W4361961142 hasAuthorship W4361961142A5087204229 @default.
- W4361961142 hasBestOaLocation W43619611422 @default.
- W4361961142 hasConcept C104317684 @default.
- W4361961142 hasConcept C150903083 @default.
- W4361961142 hasConcept C177336024 @default.
- W4361961142 hasConcept C185592680 @default.
- W4361961142 hasConcept C207001950 @default.
- W4361961142 hasConcept C2777389519 @default.
- W4361961142 hasConcept C2778227246 @default.
- W4361961142 hasConcept C2779707156 @default.
- W4361961142 hasConcept C502942594 @default.
- W4361961142 hasConcept C552990157 @default.
- W4361961142 hasConcept C55493867 @default.
- W4361961142 hasConcept C62112901 @default.
- W4361961142 hasConcept C71924100 @default.
- W4361961142 hasConcept C86803240 @default.
- W4361961142 hasConcept C94581717 @default.
- W4361961142 hasConceptScore W4361961142C104317684 @default.
- W4361961142 hasConceptScore W4361961142C150903083 @default.
- W4361961142 hasConceptScore W4361961142C177336024 @default.
- W4361961142 hasConceptScore W4361961142C185592680 @default.
- W4361961142 hasConceptScore W4361961142C207001950 @default.
- W4361961142 hasConceptScore W4361961142C2777389519 @default.
- W4361961142 hasConceptScore W4361961142C2778227246 @default.
- W4361961142 hasConceptScore W4361961142C2779707156 @default.
- W4361961142 hasConceptScore W4361961142C502942594 @default.
- W4361961142 hasConceptScore W4361961142C552990157 @default.
- W4361961142 hasConceptScore W4361961142C55493867 @default.
- W4361961142 hasConceptScore W4361961142C62112901 @default.
- W4361961142 hasConceptScore W4361961142C71924100 @default.
- W4361961142 hasConceptScore W4361961142C86803240 @default.
- W4361961142 hasConceptScore W4361961142C94581717 @default.
- W4361961142 hasLocation W43619611421 @default.
- W4361961142 hasLocation W43619611422 @default.
- W4361961142 hasOpenAccess W4361961142 @default.
- W4361961142 hasPrimaryLocation W43619611421 @default.
- W4361961142 hasRelatedWork W1518480265 @default.
- W4361961142 hasRelatedWork W1968396912 @default.
- W4361961142 hasRelatedWork W2053261751 @default.
- W4361961142 hasRelatedWork W2079243044 @default.
- W4361961142 hasRelatedWork W2131014183 @default.
- W4361961142 hasRelatedWork W2181902250 @default.
- W4361961142 hasRelatedWork W2356019003 @default.
- W4361961142 hasRelatedWork W2390950500 @default.
- W4361961142 hasRelatedWork W2906719431 @default.
- W4361961142 hasRelatedWork W3015696786 @default.
- W4361961142 isParatext "false" @default.
- W4361961142 isRetracted "false" @default.
- W4361961142 workType "article" @default.